Vol 9, No 2 (2017)

Mol Cell Pharmacol

Table of Contents

Spotlight

Spotlight on Dr. Jie An: a Pharmacogenomics and Personalized Medicine Expert Abstract PDF
Jie An 9-10

FDA Corner

FDA Expands Approved Use of Kalydeco to Treat Additional Mutations of Cystic Fibrosis Abstract PDF
  11
FDA Approves First Cancer Treatment for Any Solid Tumor With a Specific Genetic Feature Abstract PDF
  11-12
FDA Approves New Treatment to Reduce the Risk of Breast Cancer Returning Abstract PDF
  13
FDA Approves Treatment for Chronic Graft Versus Host Disease Abstract PDF
  13-14



LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 

Copyright © 2008 LumiText Publishing. All rights reserved.